Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Levillain

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2013
Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancerD Tougeron, T Lecomte, J C Pagès, et al.
British Journal of Cancer|May 29, 2008
Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective studyM Wager, P Menei, J Guilhot, et al.
European Radiology|March 5, 2009
Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoringF Staub, C Tournoux-Facon, J Roumy, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2013
Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancerD Tougeron, T Lecomte, J C Pagès, et al.
British Journal of Cancer|May 29, 2008
Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective studyM Wager, P Menei, J Guilhot, et al.
European Radiology|March 5, 2009
Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoringF Staub, C Tournoux-Facon, J Roumy, et al.
Pageof 12